136 results on '"Zigangirova N"'
Search Results
2. A novel antivirulent compound fluorothiazinone inhibits Klebsiella pneumoniae biofilm in vitro and suppresses model pneumonia
3. Fluorothiazinon inhibits the virulence factors of uropathogenic Escherichia coli involved in the development of urinary tract infection
4. Synthesis and Anti-Chlamydial Activity of Substituted N-Benzylanilines
5. The Type Three Secretion System of Pseudomonas aeruginosa as a Target for Development of Antivirulence Drugs
6. The Role of Chlamydial Colonization of the Gastrointestinal Tract in the Development and Persistence of Chronic Chlamydial Infections
7. Experimental Pharmacokinetics, Metabolism and Tissue Distribution Studies Fluorothiazinon, a of Novel Antivirulence Drug
8. The diagnostic value of aquaporin-4 antibodies in central nervous system diseases
9. Chlamydia trachomatis proteasome protein as a significant pathogenicity factor
10. Role of Chlamydia in Multiple Sclerosis
11. The role of the type-III secretion system of Gram-negative bacteria in the regulation of chronic infections
12. Development of pulmonary chlamydia infection in inbred mice strains differentiated by genetically determined sensitivity to tuberculosis infection
13. Effector proteins of chlamydiae
14. Impaired early intravaginal cell recruitment in response to Chlamydia muridarum in mice pretreated with progesterone: R2793
15. P083 Importance of preventing “healthy” part of lung microbiome
16. Mycobacterium tuberculosis-susceptible I/St mice develop severe disease following infection with taxonomically distant bacteria, Salmonella enterica and Chlamydia pneumoniae
17. IDENTIFICATION MARKERS OF INFECTION DUE TO C. TRACHOMATIS AND C. PNEUMONIAE, IN PATIENTS WITH DISEASES OF THE GASTROINTESTINAL TRACT
18. The role of chlamydial colonization of the gastrointestinal tract in the development and maintenance of chronic chlamydial infections
19. Antibacterial agents reducing the risk of resistance development
20. Neuromyelitis optica and aquaporin-associated syndromes
21. Biochemical markers of CNS demyelinating diseases
22. P1.038 Chlamydial Antigen and Nucleic Acid Detection in Liver Biopsies from Patients with Chronic Cholelithiasis
23. Development of Chlamydial Type III Secretion System Inhibitors for Suppression of Acute and Chronic Forms of Chlamydial Infection
24. ChemInform Abstract: Low-Molecular-Weight Inhibitors of NF-ϰB Signalling Pathways
25. Low-molecular-weight inhibitors of NF-κB signalling pathways
26. APO-B CONTAINING LIPOPROTEINS PROMOTE APPEARANCE OF CHLAMYDIAE INSIDE OF HEPATOCYTES
27. Development of a PCR-based method for diagnosing Mycoplasma pneumoniae infections
28. The role of type III secretion system in the development of nosocomial infections, caused by multiresistant Pseudomonas aeruginosa strains
29. Low-molecular-weight inhibitors of NF-?B signalling pathways
30. [New approaches to therapy of persistent infections: elimination of intracellular Chlamydai trachomatis by exposure to low temperature argon plasma]
31. Biomarkers in multiple sclerosis (a review and experimental data)
32. Detection of tetracycline- and erythromycin-resistant urogenital Mycoplasma strains using PCR,Vyiavlenie tetratsiklin- i éritromitsinustoichivykh shtammov urogenital'nykh mikoplasm s pomoshch'iu PTsR
33. The current status and outlook for molecular genetic methods in solving the tasks of medical microbiology,Sovremennoe sostoianie i perspektivy molekuliarno-geneticheskikh metodov v reshenii zadach meditsinskoi mikrobiologii
34. Requirements to a medical and biologic assessment and the hygienic control of the food production received from recombinant-DNA microorganisms
35. Inhibition of DNA amplification at individual genome sites in avirulent Mycoplasma pneumoniae strains,Ingibirovanie amplifikatsii DNK na otdel'nykh uchastkakh genoma u avirulentnykh shtammov Mycoplasma pneumoniae
36. (Heteroarylmethyl)benzoic Acids as a New Class of Bacterial Cystathionine γ-Lyase Inhibitors: Synthesis, Biological Evaluation, and Molecular Modeling.
37. Identification of Key TRIM Genes Involved in Response to Pseudomonas aeruginosa or Chlamydia spp. Infections in Human Cell Lines and in Mouse Organs.
38. Methylene Blue-Loaded NanoMOFs: Accumulation in Chlamydia trachomatis Inclusions and Light/Dark Antibacterial Effects.
39. [Single-domain adapted antibodies against Chlamydia trachomatis, preserving the development of chlamidic infection in vitro].
40. [Chlamydia trachomatis proteasome protein as one of the significant pathogenicity factors of exciter].
41. [Biomarkers in multiple sclerosis (a review and experimental data)].
42. [Influence of Chlamydia trachomatis type III secretion system on regulation of cytokine response].
43. [Characteristic of early mucosal immune response in mice during intravaginal infection caused by Chlamydia muridarum].
44. [New approaches to therapy of persistent infections: elimination of intracellular Chlamydai trachomatis by exposure to low temperature argon plasma].
45. [The role of the type-three secretion system of the gram-negative bacteria in regulation of chronic infections].
46. [Development of vaccine preparation for urogenital Chlamydiosis prophylaxis].
47. [Target-specific screening of antivirulence preparations for chronic infection therapy].
48. [The choice of the targets and the search for their inhibitors by means of computer simulation for the development of innovative preparations to treat of chronic bacterial infections].
49. [Effector proteins of Clamidia].
50. [Modern aspects of diagnostics of chronic chlamydiosis caused by persisting forms of Chlamydia].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.